Clinical Trial: Biomarkers of Bone Resorption in Metastatic Prostate Cancer

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Measurement of Biomarkers of Bone Resorption in Patients With Hormone Sensitive Bone Metastases From Prostate Cancer Treated With Antiandrogen Therapy and Bisphosphonates

Brief Summary: Biomarkers of bone resorption will be measured in the blood of patients with bone metastases from prostate cancer during the course of their illness. Changes in these biomarkers will be correlated with the patient's treatment with antiandrogen therapy and bisphosphonates and the response and/or progression of their cancer. It is hoped that serial measurement of these biomarkers may allow therapeutic monitoring in the future with successful individualisation of bisphosphonate therapy for metastatic prostate cancer.

Detailed Summary:
Sponsor: University of Aberdeen

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Aberdeen

Dates:
Date Received: November 2, 2010
Date Started: September 2010
Date Completion:
Last Updated: November 4, 2015
Last Verified: November 2015